Published Date:2023-06-21 Original Link:https://www.onenessbio.com/en/news_detail228_3.htm No 2 Date of announcement 2023/06/21 Time of announcement 17:31:30 Subject Oneness announces the information about the investor’s conference of 2023 Q2. To which item it meets paragraph 12 Date of events 2023/06/30 Statement Date of institutional investor conference:2023/06/30 Time of institutional investor conference:15:00 (GMT+8) Location of institutional investor conference:Online Investor...Read More

Published Date:2023-06-21 Original Link:https://www.onenessbio.com/en/news_detail227_3.htm No 1 Date of announcement 2023/06/21 Time of announcement 16:55:57 Subject The Phase 3 MRCT data and the Taiwan real-world cases of the DFU new drug, Fespixon have been accepted for an oral presentation at 2023 ADA’s 83rd Scientific Sessions. To which item it meets paragraph 12 Date of events 2023/06/24...Read More